Regn5678 (Anti-CD28 & PSMA)
Product Specifications
CAS Number
2657613-60-8
Synonyms
Nezastomig
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
REGN5678 is a bispecific antibody targeting both PSMA on prostate cancer cells and CD28 on T-cells to enhance immune activation. It is being developed for the treatment of prostate cancer by redirecting T-cells to PSMA-expressing tumors, promoting tumor cell death. M.W 145.86 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog